Siranoush Manoukian - Genetic Mutations

Author Information

Siranoush Manoukian is affiliated with the Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, located in Milan, Italy. Her research primarily focuses on genetic factors contributing to cancer, particularly breast and ovarian cancer, with a significant emphasis on BRCA1 and BRCA2 mutations.

Research Contributions

Siranoush Manoukian has made substantial contributions to the field of genetics, particularly in understanding the genetic underpinnings of cancer. Her recent works include examining the impact of Mediterranean dietary intervention on metabolic and hormonal parameters in individuals with BRCA1/2 variants, polygenic risk modeling for predicting epithelial ovarian cancer risk, and analyzing rare germline copy number variants (CNVs) in relation to breast cancer risk. She has also contributed to the management strategies for BRCA tumor testing within a multidisciplinary tumor board model.

Aliases

Siranoush Manoukian is also known by several aliases, including S Manoukian, S V Manoukian, and S. Manoukian.

Publication and Citation Metrics

Metric	Value
Citation Count	21,971
h-index	65
Paper Count	272

Publications:

The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to BRCA1/2 Variant Type

DOI: 10.3389/fgene.2022.820878

Year: 2022

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

DOI: 10.1038/s41431-022-01085-y

Year: 2022

Rare germline copy number variants (CNVs) and breast cancer risk

DOI: 10.1038/s42003-021-02990-6

Year: 2022

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

DOI: 10.1038/s41431-021-00987-7

Year: 2022

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model

DOI: 10.3389/fonc.2022.857515

Year: 2022

Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy

DOI: 10.3390/cancers13030532

Year: 2021

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

DOI: 10.1038/s41467-020-20496-3

Year: 2021

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients

DOI: 10.3390/genes12091440

Year: 2021

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

DOI: 10.1093/jnci/djab147

Year: 2021

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

DOI: 10.1056/NEJMoa1913948

Year: 2021

How Can Genetic Counseling Help Families Affected by the Delta F508 Mutation?

How Does Genetics Influence Occupational Therapy?

What Are the Challenges in Using Immunotherapy for Patients with Genetic Mutations?

What are Translocations in Genetic Mutations?

What are the Symptoms of Cystic Fibrosis?

What are the Technical Challenges?

How Do Inherited Mutations Occur?

What is the Role of Genetic Counseling?

What types of genetic mutations are associated with PAH exposure?

What Are the Consequences of Gene Amplification?

Partnered Content Networks

Relevant Topics